Chief Executive Officer and Co-founder
Thurein Htoo is the Chief Executive Officer and Co-Founder of Qlaris Bio. His vision for Qlaris Bio combines his depth of experience identifying viable new therapeutic options for patients and his willingness to explore untapped approaches to address to entrenched problems.
Prior to founding Qlaris Bio with Barbara Wirostko, MD, FARVO, Mr. Htoo was Chief Business Officer of Qrativ, a joint venture between Mayo Clinic and nference, an AI-driven healthcare company. Before Qrativ, he was VP, Head of Business Development and Corporate Strategy at Novelion Therapeutics, where he was instrumental in negotiating and orchestrating the merger of QLT Inc. and Aegerion Pharmaceuticals, both public companies, to form Novelion. Previously, Mr. Htoo worked at Pfizer for nearly a decade, holding leadership positions in Business Development and Disease Area strategy development, with a primary focus on Ophthalmology and Rare Diseases. Before Pfizer, he worked in Business Development at NPS Pharmaceuticals, where he helped execute a co-promotion deal with Allergan for Restasis for the treatment of dry eye.
Mr. Htoo received an MBA from the University of Rochester and both an MS in Physiology and a BAS in Neurobiology and Psychology from UC Davis.